[Comparative randomized controlled study between human follicle- stimulating hormone (FSH-HP) and human menopausal gonadotropins (hMG) in in vitro fertilization].
We present the results of a prospective randomized trial comparing the issue of IVF-ET and of ICSI when either highly purified human folliculostimulin (FSH-HP) or human menopausal gonadotrophin (hMG) is used. There seems to be a trend to a better rate of ongoing pregnancies when FSH-HP is used although not statistically significant. The study has been stopped due to the lack of hMG.
Mayenga
J M
JM
Service de Gynécologie-Obstétrique et Reproduction Humaine, CHI J. Rostand, Sèvres.
Belaisch-Allart
J
J
Chouraqui
A
A
Tesquier
L
L
Serkine
A M
AM
Cohen
J
J
Plachot
M
M
Mandelbaum
J
J
D000328:Adult; D005260:Female; D005300:Fertility Agents, Female / Q000627:therapeutic use*; D005307:Fertilization in Vitro / Q000379:methods*; D005640:Follicle Stimulating Hormone / Q000627:therapeutic use*; D006801:Humans; D007247:Infertility, Female / Q000188:drug therapy*; D008596:Menotropins / Q000627:therapeutic use*; D011247:Pregnancy; D011256:Pregnancy Outcome; D011446:Prospective Studies
D005300:Fertility Agents, Female; D008596:Menotropins; D005640:Follicle Stimulating Hormone